.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Mallinckrodt
AstraZeneca
Colorcon
Fish and Richardson
Medtronic
Boehringer Ingelheim
US Army
Moodys
Teva

Generated: September 23, 2017

DrugPatentWatch Database Preview

Rose bengal sodium i-131 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rose bengal sodium i-131 and what is the scope of rose bengal sodium i-131 patent protection?

Rose bengal sodium i-131
is the generic ingredient in two branded drugs marketed by Sorin and Bracco, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and one drug master file entries for rose bengal sodium i-131.

Summary for Generic Name: rose bengal sodium i-131

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list101
Clinical Trials: see list2,603
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rose bengal sodium i-131 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
ROBENGATOPE
rose bengal sodium i-131
INJECTABLE;INJECTION016224-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sorin
SODIUM ROSE BENGAL I 131
rose bengal sodium i-131
INJECTABLE;INJECTION017318-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
ROBENGATOPE
rose bengal sodium i-131
INJECTABLE;INJECTION016224-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
ROBENGATOPE
rose bengal sodium i-131
INJECTABLE;INJECTION016224-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Army
Federal Trade Commission
Farmers Insurance
Chubb
UBS
McKinsey
Dow
Argus Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot